Premium
Hostility in cancer patients as an underexplored facet of distress
Author(s) -
Grassi Luigi,
Belvederi Murri Martino,
Riba Michelle,
de Padova Silvia,
Bertelli Tatiana,
Sabato Silvana,
Nanni Maria Giulia,
Caruso Rosangela,
Ounalli Heifa,
Zerbinati Luigi
Publication year - 2021
Publication title -
psycho‐oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.41
H-Index - 137
eISSN - 1099-1611
pISSN - 1057-9249
DOI - 10.1002/pon.5594
Subject(s) - hostility , clinical psychology , distress , psychiatry , anxiety , mental health , quality of life (healthcare) , coping (psychology) , psychology , medicine , psychotherapist
Objective In the present study, we aimed to assess hostility and to examine its association with formal psychiatric diagnosis, coping, cancer worries, and quality of life in cancer patients. Methods The World Health Organization (WHO) Composite International Diagnostic Interview (CIDI) to make an ICD‐10 (International Classification of Disease) psychiatric diagnosis was applied to 516 cancer outpatients. The patients also completed the Brief Symptom Inventory‐53 to assess hostility (BSI‐HOS), and the Mini‐Mental Adjustment to cancer scale (Mini‐MAC). A subset of patients completed the Cancer Worries Inventory (CWI), the Openness Scale, and the Quality of Life Index. Results By analyzing the distribution of the responses 25% of the patients had moderate and 11% high levels of hostility, with about 20% being BSI‐HOS “cases.” Hostility was higher in patients with a formal ICD‐10 psychiatric diagnosis (mainly major depression, other depressive disorders, anxiety disorders) than patients without ICD‐10 diagnosis. However, about 25% of ICD‐10‐non cases also had moderate‐to‐high hostility levels. Hostility was associated with Mini‐MAC hopelessness and anxious preoccupation, poorer quality of life, worries (mainly problems sin interpersonal relationships), and inability to openly discuss these problems within the family. Conclusions Hostility and its components should be considered as dimensions to be more carefully explored in screening for distress in cancer clinical settings for its implications in negatively impacting on quality of life, coping and relationships with the family, and possibly the health care system.